US OptionsDetailed Quotes
BIIB240712P222500
- 0.71
- 0.000.00%
15min DelayClose Jul 12 16:00 ET
0.00High0.00Low
0.71Open0.71Pre Close0 Volume40 Open Interest222.50Strike Price0.00Turnover335.21%IV3.59%PremiumJul 12, 2024Expiry Date0.00Intrinsic Value100Multiplier-1DDays to Expiry0.71Extrinsic Value100Contract SizeAmericanOptions Type-0.1645Delta0.0309Gamma324.03Leverage Ratio-25.1954Theta0.0000Rho-53.29Eff Leverage0.0059Vega
Biogen Stock Discussion
$Merck & Co(MRK.US)$ to acquire EyeBio
$Biogen(BIIB.US)$ to acquire HI-Bio™
$Johnson & Johnson(JNJ.US)$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals(RPHM.US)$
$Novartis AG(NVS.US)$ to acquire Mariana Oncology
What companies will be next? 🤔
$Biogen(BIIB.US)$ to acquire HI-Bio™
$Johnson & Johnson(JNJ.US)$ to acquire Proteologix
OnKure, Inc. merger with $Reneo Pharmaceuticals(RPHM.US)$
$Harmony Biosciences(HRMY.US)$ acquired Epygenix Tx
What companies will be next? 🤔
⇨ Expands immunology portfolio 🧬
⇨ $1.15B upfront and up to $650M potential milestone payments 💰
⇨ Includes lead asset felzartamab, fully human anti-CD38 monoclonal antibody
» demonstrated clinical proof of concept in rare immune-mediated indications
» Planned Ph3 trial
» Holdings in Top 20: 70.21%
» Qtr over Qtr Change**: +21.81%
Top Holdings:
$Ascendis Pharma A/S(ASND.US)$
$Vaxcyte(PCVX.US)$
$Legend Biotech(LEGN.US)$
$Janux Therapeutics(JANX.US)$
$Aerovate(AVTE.US)$
$Rhythm Pharmaceuticals(RYTM.US)$
$Evolent Health(EVH.US)$
$NewAmsterdam Pharma(NAMS.US)$
$RxSight(RXST.US)$
$TYRA BIOSCIENCES, INC.(TYRA.US)$
$Edgewise Therapeutics(EWTX.US)$
$4D Molecular Therapeutics(FDMT.US)$
$Biogen(BIIB.US)$
$PepGen(PEPG.US)$
...
Specifically for Tesla, it’s quite amazing that it is rallying off a very poor earnings.
Sometimes, the market rallies on bad earnings could be because the bad results weren’t as bad as previously feared. Sometimes, peope buy into the “future growth” theory.
Whether all these rebounds are dead cat bounces, it remains to be seen.
PS: definitely not complaining about this pop
$SPDR S&P 500 ETF(SPY.US)$ $S&P 500 Index(.SPX.US)$ $Visa(V.US)$ $Boeing(BA.US)$ $Texas Instruments(TXN.US)$ $Biogen(BIIB.US)$ $Airbnb(ABNB.US)$ $Bank of America(BAC.US)$ $Disney(DIS.US)$ $Apple(AAPL.US)$ $Meta Platforms(META.US)$ $Microsoft(MSFT.US)$ $NVIDIA(NVDA.US)$ $Taiwan Semiconductor(TSM.US)$ $Super Micro Computer(SMCI.US)$ $Coinbase(COIN.US)$ $Alphabet-A(GOOGL.US)$
Gapping up
$Tesla(TSLA.US)$ stock soared 12% following the announcement of earlier releases for "more affordable" car versions, despite first-quarter results falling short of Wall Street estimates.
$AT&T(T.US)$ stock increased by 3.6% after reporting stronger-than-expected subscriber growth and surpassing free cash flow growth in the first quarter.
$Visa(V.US)$ stock grew 2.4% as the credit card company's second...
No comment yet